Cargando…
Point of care testing to monitor INR control in patients with antiphospholipid syndrome
Patients with antiphospholipid syndrome (APS) typically require lifelong warfarin anticoagulation following a thrombotic event due to a significant risk of recurrent thrombosis. Point of care testing (POCT) to monitor INR is discouraged in patients with APS as interactions between antiphospholipid a...
Autores principales: | Masucci, Michael, Li Kam Wa, Annabelle, Shingleton, Emilia, Martin, Jonathan, Mahir, Zahra, Breen, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422004/ https://www.ncbi.nlm.nih.gov/pubmed/36051047 http://dx.doi.org/10.1002/jha2.522 |
Ejemplares similares
-
Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016) -
Thrombocytopenia and PT-INR in patients with anorexia nervosa and severe liver dysfunction
por: Kurisu, Ken, et al.
Publicado: (2023) -
Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement
por: Chen, Qiu-lin, et al.
Publicado: (2015) -
Neurological manifestations in patients with antiphospholipid syndrome
por: Etemadifar, Masoud, et al.
Publicado: (2013) -
Performance of the microINR Point-of-Care System Used by Self-Testing Patients: A Multicenter Clinical Trial
por: Refaai, Majed A., et al.
Publicado: (2021)